MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-HP-11-0018951
Martin & Brown Bio-Sciences Private Limited
Martin & Brown Bio-Sciences Private Limited - pharma in Nalagarh, Himachal Pradesh, India. Directors, charges & compliance details.
Revenue · FY 2025
₹88.52 Cr
▲ 75% YoY
Net profit · FY 2025
₹1.51 Cr
Net margin 1.7%
EBITDA · FY 2025
₹4.66 Cr
EBITDA margin 5.3%
Authorised capital
₹6.4 Cr
Registered with MCA
Paid-up capital
₹5.53 Cr
Issued & subscribed
Open charges
₹18.04 Cr
Secured borrowings
Company age
3 yrs
Est. 2023
Directors on board
2
As per MCA filings
About Martin & Brown Bio-Sciences Private Limited
Data last updated:
Martin & Brown Bio-Sciences Private Limited is a private limited company based in Nalagarh, Himachal Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 April 2023.
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U21009HP2023PTC010046.
The company has an authorised share capital of ₹6.4 Cr and a paid-up capital of ₹5.53 Cr. It is led by directors Puneet Maini and Vineet Maini.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Khasra No 918/419 Malku Majra, Nalagarh, Himachal Pradesh, India – 173205.
As per the financials filed for FY 2025, the company reported a revenue of ₹88.52 Cr, a growth of 75% compared to the previous year. For the same year it recorded a net profit of ₹1.51 Cr (net margin 1.7%) and EBITDA of ₹4.66 Cr (EBITDA margin 5.3%).
As per MCA filings, the company has open charges of ₹18.04 Cr on record. Court records list 20 cases involving the company, including 12 filed by the company and 8 filed against it; 12 cases are pending.
Martin & Brown Bio-Sciences Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-11-0018951).
Company Details of Martin & Brown Bio-Sciences Private Limited
CIN U21009HP2023PTC010046
Registration Number 010046
Incorporation Date 28 April 2023
ROC Himachal Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Medium
Udyam Registration UDYAM-HP-11-0018951
Key People
Puneet Maini Director Vineet Maini Director Recognitions & Rankings of Martin & Brown Bio-Sciences
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressKhasra No 918/419 Malku Majra, Nalagarh, Himachal Pradesh, India – 173205
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Martin & Brown Bio-Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity
The main business activity of Martin & Brown Bio-Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Financials of Martin & Brown Bio-Sciences Private Limited
FY 2025 filings availableMartin & Brown Bio-Sciences Private Limited reported revenue of ₹88.52 Cr (up 75% YoY) for FY 2025.
Revenue · FY 2025
₹88.52 Cr ▲ 75%
Net profit · FY 2025
₹1.51 Cr margin 1.7%
EBITDA · FY 2025
₹4.66 Cr margin 5.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 75%
EBITDA CAGR growth
1 year
▲ 29%
Revenue rose 75% in the latest year. EBITDA rose 29% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | |
| Other Income | •••• | |
| Total Revenue | •••• | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | ₹4.66 Cr | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | ₹1.51 Cr | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 5.3% | |
| Net Profit Margin | 1.7% | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2023-24, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Martin & Brown Bio-Sciences are in the company report.
: available in the company report
Board of Directors of Martin & Brown Bio-Sciences Private Limited
Martin & Brown Bio-Sciences has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Puneet Maini | Director | 28 Apr 2023 | 3 Years 5 Months | Current |
| Vineet Maini | Director | 28 Apr 2023 | 3 Years 5 Months | Current |
Peer Comparison
Martin & Brown Bio-Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medilux Laboratories Pvt Ltd | ₹89.42 Cr (FY 2018) | •••• | •••• | -2.0% | •••• | Indore, Madhya Pradesh, India |
| Evertogen Life Sciences Limited | ₹89.28 Cr (FY 2024) | •••• | •••• | 51.0% | •••• | Hyderabad, Telangana, India |
| U S Pharma (India) Private Limited | ₹89.26 Cr (FY 2025) | •••• | •••• | 421.0% | •••• | Mumbai, Maharashtra, India |
| Gnosis Pharmaceuticals Private Limited | ₹88.76 Cr (FY 2024) | •••• | •••• | 18.0% | •••• | New Delhi, Delhi, India |
| Martin & Brown Bio-Sciences Private Limited this company | ₹88.52 Cr (FY 2025) | •••• | •••• | 75.0% | •••• | Nalagarh, Himachal Pradesh, India |
| Ravian Life Science Private Limited | ₹88.41 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Haridwar, Uttarakhand, India |
| SRS Pharmaceuticals Private Limited | ₹88.26 Cr (FY 2025) | •••• | •••• | -10.0% | •••• | Mumbai, Maharashtra, India |
| Appasamy Ocular Devices Private Limited | ₹87.93 Cr (FY 2022) | •••• | •••• | 60.0% | •••• | Chennai, Tamil Nadu, India |
| BDH Industries Limited Listed | ₹87.41 Cr (FY 2024) | •••• | •••• | 16.0% | •••• | Mumbai, Maharashtra, India |
Peers are the companies nearest to Martin & Brown Bio-Sciences by revenue, above and below it, in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings
Open charges
₹18.04 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Feb 2024 | State Bank of India | ₹18.04 Cr | Open |
Total charge records: 1 View all charges
Legal Cases
Martin & Brown Bio-Sciences Private Limited has 20 court cases on record: 12 filed by Martin & Brown Bio-Sciences, 8 filed against it. 12 cases are pending and 8 are disposed.
Total cases
20
Filed by the company
12
Filed against the company
8
Pending
12
Disposed
8
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 11 | 1 | 6 |
| District courts | 9 | 7 | 6 |
Cases on record (5 of 20)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, West, Delhi | Execution petition | Filed against the company by Om Logistics Limited | Pending |
| Patna High Court | Court case (CWJC) | Filed by the company against The Managing Director, Bihar Medical Services and Infrastructure Corporation Ltd., and 3 others | Pending |
| Patna High Court | Court case (REQ. CASE) | Filed by the company against Bihar Medical Services and Infrastructure Corporation Ltd., | Pending |
| High Court of Delhi | Court case (RFA(COMM)) | Filed by the company against Om Logistics Limited | Pending |
| Patna High Court | Court case (CWJC) | Filed by the company against Bihar Medical Services and Infrastructure Corporation Ltd., and 1 other | Disposed |
: available in the company report
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance
Employment history and EPFO contributions of people linked to Martin & Brown Bio-Sciences.
: available in the company report
Recent Activity
Martin & Brown Bio-Sciences Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Puneet Maini was appointed as Director on 28 Apr 2023.
AGM
Martin & Brown Bio-Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with State Bank Of India of Rs. 18.04 Cr registered on 09 Feb 2024 with Charge ID 100888531 was modified on 09 Sep 2025.
Filing
Martin & Brown Bio-Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Himachal Pradesh.
Charges
A charge with State Bank Of India amounted to Rs. 18.04 Cr with Charge ID 100888531 was registered on 09 Feb 2024.
Appointed
Puneet Maini was appointed as Director.
Appointed
Vineet Maini was appointed as Director.
Incorporation
28 Apr 2023
Martin & Brown Bio-Sciences Private Limited was registered on 28 Apr 2023 with Roc Himachal Pradesh & aged 3 years 5 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
MSME Payment Delays
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
: available in the company report
MCA Filings & Documents
: available in the company report
Frequently Asked Questions
Martin & Brown Bio-Sciences is an active private limited company based in Nalagarh, Himachal Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 April 2023 (3+ years old) and is registered under CIN U21009HP2023PTC010046.
Martin & Brown Bio-Sciences has 2 current directors:
- Puneet Maini - Director
- Vineet Maini - Director
The latest financial statements of Martin & Brown Bio-Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Martin & Brown Bio-Sciences is U21009HP2023PTC010046. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Martin & Brown Bio-Sciences has 20 court cases on record: 12 filed by the company and 8 filed against it. 12 are pending. Most are in the high courts.
Martin & Brown Bio-Sciences was incorporated on 28 April 2023, making it 3+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
The peers of Martin & Brown Bio-Sciences by revenue are Medilux Laboratories Pvt Ltd, Evertogen Life Sciences Limited, U S Pharma (India) Private Limited, Gnosis Pharmaceuticals Private Limited, Ravian Life Science Private Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Puneet Maini was appointed as Director on 28 Apr 2023. Vineet Maini was appointed as Director on 28 Apr 2023.
Yes, Martin & Brown Bio-Sciences is registered as a medium enterprise under Udyam registration (number: UDYAM-HP-11-0018951).
The registered office of Martin & Brown Bio-Sciences is at Khasra No 918419 Malku Majra, Nalagarh, Himachal Pradesh, India – 173205.
Martin & Brown Bio-Sciences operates in the pharma industry, in the drug formulation and development segment.